Outlook Therapeutics OTLK
NASDAQ OTLK
$0.58 +0.01 (+1.48%)
As of: Oct 1, 2026 · 3:59 PM EDT

Outlook Therapeutics (OTLK) Shares Outstanding (2015 - 2026)

Updated

Outlook Therapeutics (OTLK) reported Shares Outstanding of 136.74 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 270.0% from 36.96 million a year earlier and up 67.1% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Shares Outstanding (2015 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Outlook Therapeutics posted Shares Outstanding of 34.8 million, up 87.6% from FY2024.

  • Shares Outstanding has increased for ten consecutive fiscal years, with a five-year compound annual growth rate of 57.2% (FY2020 to FY2025).
  • By fiscal year, Shares Outstanding came in at 18.55 million in FY2024 (+48.3%), 12.51 million in FY2023 (+18.0%), 10.6 million in FY2022 (+38.9%) and 7.63 million in FY2021 (+110.4%).
  • The fiscal Q3 2026 figure ranks as the highest quarterly Shares Outstanding in data going back to fiscal Q2 2015.
  • Year over year, Shares Outstanding has now increased in each of the last 42 quarters, with growth averaging 122.6% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding ranged from 11.2% (fiscal Q2 2024) to 270.0% (fiscal Q3 2026).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at 81.84 million (Q2 2026), 60.21 million (Q1 2026) and 34.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 Outlook Therapeutics 77.94 Mn 42.19 Mn -8,265.00 136.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136.74 Mn
Mar 31, 2026 81.84 Mn
Dec 31, 2025 60.21 Mn
Sep 30, 2025 34.80 Mn
Jun 30, 2025 36.96 Mn
Mar 31, 2025 30.87 Mn
Dec 31, 2024 24.23 Mn
Sep 30, 2024 18.55 Mn
Jun 30, 2024 23.23 Mn
Mar 31, 2024 14.27 Mn
Dec 31, 2023 13.01 Mn
Sep 30, 2023 12.51 Mn
Jun 30, 2023 12.84 Mn
Mar 31, 2023 12.83 Mn
Dec 31, 2022 11.37 Mn
Sep 30, 2022 10.60 Mn
Jun 30, 2022 11.02 Mn
Mar 31, 2022 10.95 Mn
Dec 31, 2021 9.41 Mn
Sep 30, 2021 7.63 Mn
API Access

Outlook Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=OTLK&period=max&api_key=YOUR_API_KEY